reviewJournal of Cerebral Blood Flow & MetabolismMay 23, 2007Closed access

Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands

National Institute of Mental Health · GlaxoSmithKline (United Kingdom) · +27 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

An international group of experts in pharmacokinetic modeling recommends a consensus nomenclature to describe in vivo molecular imaging of reversibly binding radioligands.

No related works found for this paper.